The estimated Net Worth of James L Coyne is at least $9.59 Thousand dollars as of 21 May 2018. Mr. Coyne owns over 3,000 units of STRATA Skin Sciences Inc stock worth over $9,585 and over the last 8 years he sold SSKN stock worth over $0. In addition, he makes $0 as Director at STRATA Skin Sciences Inc.
James has made over 1 trades of the STRATA Skin Sciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 3,000 units of SSKN stock worth $5,040 on 21 May 2018.
The largest trade he's ever made was buying 3,000 units of STRATA Skin Sciences Inc stock on 21 May 2018 worth over $5,040. On average, James trades about 1,000 units every 0 days since 2017. As of 21 May 2018 he still owns at least 3,000 units of STRATA Skin Sciences Inc stock.
You can see the complete history of Mr. Coyne stock trades at the bottom of the page.
James Coyne has been appointed as Director of the Company. Mr. Coyne is currently the CEO of Modevity LLC, a software company he founded in 2004, and which produces the ARALOC™, a market leading digital content distribution program.
James's mailing address filed with the SEC is 100 Lakeside Dr #100, Horsham, PA 19044, USA.
Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ..., and Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.
formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.
STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include: